TrialClinical cancer research : an official journal of the American Association for Cancer Research2022

Clinical Outcomes and Immune Markers by Race in a Phase I/II Clinical Trial of Durvalumab Concomitant with Neoadjuvant Chemotherapy in Early-Stage TNBC.

Julia Foldi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.